POLMATINE 20mg tablets medication leaflet

N06DX01 memantine • Nervous system | Anti-dementia drugs | Other anti-dementia drugs

Memantine is a medication used to treat moderate to severe dementia associated with Alzheimer’s disease. It works by blocking NMDA (N-methyl-D-aspartate) receptors in the brain, reducing the excessive effects of glutamate, a neurotransmitter that, in high amounts, can contribute to nerve cell damage.

Memantine helps improve cognitive function, memory, and the ability to perform daily activities, but it does not cure Alzheimer’s disease. It is usually administered in tablet or oral solution form, with the dose gradually adjusted to minimize side effects.

Side effects may include dizziness, headaches, constipation, drowsiness, or confusion. In rare cases, hallucinations or high blood pressure may occur. It is important to take the medication as prescribed by a doctor, with regular monitoring of the patient’s condition.

General data about POLMATINE 20mg

Substance: memantine

Date of last drug list: 01-01-2014

Commercial code: W60157012

Concentration: 20mg

Pharmaceutical form: tablets

Quantity: 112

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Concentrations available for memantine

10mg, 10mg/g, 10mg/ml, 15mg, 20mg, 5mg, 5mg/10mg/15mg/20mg, 5mg/dose, 5mg/dose eliberata

Other substances similar to memantine